Europe's largest drugs company, GSK, is to register a new meningitis vaccine without the intention of making money.

A battle royale begins over cervical cancer vaccines between Glaxo and Merck, with Mike Huckman, CNBC pharmaceuticals reporter

GlaxoSmithKline ...SE: GSK] announced that the U.S. Food and Drug Administration (FDA) has approved FluLaval(TM) [Influenza Virus Vaccine] for the active immunization of adults 18 years and older ...

UK drugs firm GlaxoSmithKline believes it has developed a vaccine for the H5N1 deadly strain of avian flu.

1906

...GlaxoSmithKline ...GSK] ...FDA) has approved FluLaval(TM) [Influenza Virus Vaccine] for the active immunization of adults 18 years and older against influenza disease, commonly known as the flu, ...